Disruptive influence

Cachexia, a condition that kills about one-fifth of cancer patients, may be linked to Rb—a protein that is already linked to various cancers—moving from the cell nucleus to the cytoplasm.

W ith more than 11,000 papers pub lished on it, one would assume that we know all there is to know about ret inoblastoma protein (Rb). This protein has been the subject of intense study ever since it was realized that the inactivation of Rb is a fundamen tal event in the development of cancer. However, it has been difficult to determine what Rb does in normal cells because it appears to be involved in a wide range of processes, including transcrip tional regulation, chromatin remodelling, the cell cycle and apoptosis. Now, in eLife, Keigo Araki, Yoichi Taya and colleagues at the National Uni versity of Singapore report an intriguing new aspect of Rb. They show that, under certain con ditions, Rb can move from the cell nucleus-where it is usually found-to the cytoplasm, where it disrupts the basic units of muscle (Araki et al., 2013).
This finding is important because it could help explain why latestage cancer patients often encounter progressive muscle weakness and atro phy that cannot be reversed by increased calorie intake (reviewed in Fearon et al., 2012). It has been estimated that this condition-which is called cachexia, and which also involves changes to the neuroendocrine system, the immune system and adipose tissue-is the direct cause of death for approximately 20% cancer patients, so obtaining a better understanding of the molecular mecha nisms responsible for it is of paramount import ance. According to the current understanding of cachexia, various inflammatory cytokines lead to the upregulation of enzymes called E3 ubiquitin ligases, which then mediate the breakdown of the proteins that make up sarcomeres, which are the basic building blocks of muscle. At the same time, the expression of the genes that code for skeletal muscle are downregulated.
The new results demonstrate that Rb can de stabilize the sarcomeric proteins in the muscle cells of cancer patients: by interacting with mDia1 (a protein that nucleates the formation of actin filaments in the cytoplasm), Rb may influence both the assembly of actin filaments and the gen eration of force by these filaments (Figure 1). It remains to be seen whether the interaction between mDia1 and Rb is the consequence of the activity of E3 ligases or of altered cellular energy balance, or if it precedes these stages in the weak ening of skeletal muscle. Indeed, it has been suggested that the filaments are more suscepti ble to degradation after they have been dislodged from the sarcomere (Solomon and Goldberg, 1996). The equivalent of mDia1 in C. elegans is known to be important in the attachment of actin filaments to a structure called the Zline, which marks the edge of the sarcomere (Figure 1; Mi-Mi et al., 2012). It is conceivable, therefore, that the colocalization of mDia1 and Rb near the Copyright Cossu et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Disruptive influence
Cachexia, a condition that kills about one-fifth of cancer patients, may be linked to Rb-a protein that is already linked to various cancersmoving from the cell nucleus to the cytoplasm. A considerable amount of evidence about the diverse range of roles performed by Rb in the cytoplasm has emerged in recent years. For example, it has been demonstrated that Rb can be localized in mitochondria and also shown that it is involved in inducing apoptosis (Hilgendorf et al., 2013). Moreover, in various cells Rb is methylated by an enzyme called SMYD2, which enhances the phosphorylation of Rb and the recruitment of additional cofactors (Saddic et al., 2010;Cho et al., 2012). And in separate studies of skeletal muscle cells, SMYD1 and SMYD2 have been found to be vital for forming complexes with myosin, myosin chaperones and titin. Loss of SMYD function is also known to lead to the disruption of sarcomere (Just et al., 2011;Donlin et al., 2012;Li et al., 2013).
These data place Rb in a protein interaction network, which now includes both myosin and actin filaments of skeletal muscle, along with their regulatory factors. We can expect exciting times in unravelling how this stress responsive path way is finetuned to sense the balance between healthy cells, sarcomere breakdown and apoptosis. It will be intriguing to study how these cytoplasmic functions of Rb relate to its role as a transcriptional regulator in the nucleus and how Rb is distributed between different cellular compartments.
With these newly identified functions, Rb has managed to surprise us once again. The loss of Rb has long been associated with cancer. Now it Figure 1. A simplified scheme showing the translocation of Rb from the nucleus to the cytoplasm, and the effect it has on sarcomeres. TNFα (tumour necrosis factoralpha) is a cytokine that may, in certain cases, kill cancer cells. When TNFα binds to its receptor on the surface of a normal cell (1), it triggers a signal transduction cascade that leads to the phosphorylation of Rb in the nucleus (2) by the enzyme CDK4. The phosphorylated Rb (3) separates from the DNA, allowing transcription of E2F target genes, and moves to the cytoplasm, where it binds to mDia1 at the Z line (4). This leads to the destabilization of the actin filaments in the sarcomere and to impaired muscle function. The enzyme SMYD methylates the Rb, which contributes to sarcomere stability (5). There is also evidence that Rb accumulates in the mitochondria, where it seems to play a role in apoptosis (6). The figure was produced using Servier Medical Art (http://www.servier.com).
appears that native Rb can also have detrimental effects for patients away from cancer tissue. And while the presence of Rb in the cytoplasm of cells in skeletal muscles can have damaging conse quences, we still do not know if there is an under lying physiological role for Rb in the healthy turnover sarcomeres. Ultimately, of course, we hope it will be possible to minimize cancerrelated muscle wasting by modifying the behaviour of Rb in skeletal muscle cells.